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DNA methylation is closely involved in the regulation of cellular differentiation, including chondrogenic
differentiation of mesenchymal stem cells. Recent studies showed that Ten–eleven translocation (TET)
family proteins converted 5-methylcytosine (5mC) to 5-hydroxymethylcytosine, 5-formylcytosine and
5carboxylcytosine by oxidation. These reactions constitute potential mechanisms for active demethyla-
tion of methylated DNA. However, the relationship between the DNA methylation patterns and the ef-
fects of TET family proteins in chondrocyte differentiation is still unclear. In this study, we showed that
DNA hydroxylation of 5mC was increased during chondrocytic differentiation of C3H10T1/2 cells and that
the expression of Tet1 was particularly enhanced. Moreover, knockdown experiments revealed that the
downregulation of Tet1 expression caused decreases in chondrogenesis markers such as type 2 and type
10 collagens. Furthermore, we found that TET proteins had a site preference for hydroxylation of 5mC on
the Insulin-like growth factor 1 (Igf1) promoter in chondrocytes. Taken together, we showed that the
expression of Tet1 was speciﬁcally facilitated in chondrocyte differentiation and Tet1 can regulate
chondrocyte marker gene expression presumably through its hydroxylation activity for DNA.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
DNA methylation is a well-known epigenomic mark involved in
gene silencing [1,2]. Methylation of DNA affects the transcription
of genes related to various cellular processes such as differentia-
tion. Moreover, the variation of DNA methylation between tissues
has been termed “tissue-dependent differentially methylated re-
gions” (T-DMRs). This methylation diversity reportedly contributes
to tissue-speciﬁc gene expression [3].
Recently, Ten–eleven translocation (TET) family proteins (TET1/
2/3) were identiﬁed as the family of enzymes that sequentially
converted 5-methylcytosine (5mC) into 5-hydroxymethylcytosine
(5hmC), 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC)
[4,5]. This series of reactions is considered a potential mechanism
for active demethylation of 5mC [6]. The physiological function of
each TET protein has distinguishing features. TET1 has been re-
ported to be involved in the genetic regulation of memory for-
mation [7,8] and cancer development [9]. TET2 plays a critical roleB.V. This is an open access article u
hydroxymethylcytosine; Tet,
lagen 10; Igf1, insulin-like
Yokoyama).in hematopoietic differentiation and its mutations have been fre-
quently observed in myeloid malignancies [10]. TET3 is expressed
particularly in oocytes and is indispensable for paternal DNA de-
methylation after fertilization [11]. As described herein, although
TET proteins have similar enzymatic activities, their biological
signiﬁcance includes various cellular processes in different organs.
DNA methylation is a key factor for cell fate decisions, such as
differentiation from mesenchymal stem cells into adipocytes,
myocytes and chondrocytes [12]. Many reports have demonstrated
that there are alterations of DNA methylation states during adi-
pocyte and myocyte differentiation [13,14], and speciﬁc methyla-
tion of CpG dinucleotides is required for proper adipocyte differ-
entiation [15]. Furthermore, the state of DNA methylation re-
portedly changes during chondrocyte differentiation [16].
Chondrocytes are established through subsequent differentia-
tion steps, consisting of resting, proliferative and hypertrophic
chondrocytes [17]. During differentiation, various transcription
factors, for instance, SRY-box containing gene 9 (Sox9) play im-
portant roles and are essential for normal early stage chondrocyte
differentiation [18]. Furthermore, a recent study revealed that
epigenetic regulators, such as ERG-associated protein with a SET
domain (ESET) and autoimmune regulator (Aire) also controlled
chondrocyte differentiation through histone modiﬁcation [19,20].
However, it is still unclear how TET family proteins are involved innder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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In this paper, we evaluated the relationship between chon-
drocyte differentiation and the hydroxylation of methylated DNA
by TET proteins using the mesenchymal stem cell line C3H10T1/2.
We found that the amount of hydroxyl-methylated DNA increased
during chondrocyte differentiation. From knockdown experi-
ments, we found that TET1 had a role in the expression of chon-
drocyte marker genes.2. Materials and methods
2.1. Cell culture, cell differentiation, and Alcian blue staining
Mouse C2C12 cells were cultured in Dulbecco’s modiﬁed Ea-
gle’s medium (DMEM, Wako, Osaka, Japan) supplemented with
20% fetal bovine serum (FBS, Gibco, USA) and antibiotics. Mouse
3T3-L1 and C3H10T1/2 cells were maintained in DMEM containing
10% FBS and antibiotics. The latter two strains were grown at 37 °C
in 5% CO2. For myogenic differentiation, the culture medium of
C2C12 cells was exchanged for DMEM containing 0.5% FBS. In ac-
cord with a previous report [21], adipocyte differentiation of 3T3-
L1 cells was induced using AdipoInducer Reagent (Takara Bio Inc.,
Otsu, Japan). For chondrocyte differentiation, C3H10T1/2 cells
were placed in high-density micromass cultures with 100 ng/mL
of recombinant human bone morphogenetic protein 2 (BMP2,
OSTEOPHARMA, Osaka, Japan) as previously reported [19].
2.2. Genomic DNA preparation, dot blotting and densitometric
analysis
Genomic DNA puriﬁcation and dot blotting were carried out as
previously described [22]. Brieﬂy, the cells were lysed with gen-
ome extraction buffer (50 mM Tris–HCl, 20 mM EDTA, 100 mM
NaCl, and 1% SDS, pH 7.9) with 0.15 mg/mL Proteinase K. After
phenol/chloroform extraction and isopropanol precipitation, 2 μg
DNA of each samples were subjected to dot blot assay using 5hmC
antibody (Active Motif, USA). As a standard for comparison, 1 μg
DNA derived frommouse embryonic stem cells (mESc) was blotted
in the same membranes. Densitometric analysis was carried out by
ImageJ.
2.3. RNA isolation, complementary DNA (cDNA) synthesis, poly-
merase chain reaction (PCR), and statistics
RNA isolation, cDNA synthesis and PCR were conducted as
previously described [22]. The sequences of the primer sets are
shown in Supplemental Table 1. All values are means 7 standard
deviations from three independent experiments. We used a two-
tailed Student’s t test to analyze the differences between two
groups.
2.4. DNA methylation analysis using restriction enzymes and
glucosyltransferase
For the measurement of DNA methylation state, the genomic
DNA was digested with either MspI (that recognized and cleaved
CCGG sequences independent of its methylation) or HapII (that
recognized the same sequences as MspI but could not cleave
methylated DNA). These digested DNAs ware subjected to quan-
titative PCR (qPCR) analysis using primers designed for the Insulin-
like growth factor 1 (Igf1) promoter. To determine the level of
5hmC, we sequentially treated the genomic DNA with MspI and
T4-β-glucosyltransferase (BGT, New England Biolabs, USA) fol-
lowing the manufacturer’s instructions. The data were normalized
to the qPCR intensities of the uncut samples.2.5. Preparation of cell extracts, Western blotting and antibodies
As previously described [22], cell lysates were prepared in TNE
buffer (20 mM Tris–HCl, 137 mM NaCl, two mM EDTA, 1% NP-40,
and protease inhibitor, pH 7.9) with sonication. Western blotting
analysis was performed using α-Tet1 (Millipore, USA), α-Tet2
(Sigma, USA), α-Collagen2 (Col2, Santa Cruz, USA), and α-actin
(Santa Cruz).
2.6. Plasmids for shRNA expression, retroviral production and
infection
For short hairpin RNA (shRNA) expression plasmids, oligonu-
cleotides were inserted into a pSUPER.retro.hygro vector that was
generated from pSUPER.retro.puro (Oligoengine) and had the re-
sistance gene to hygromycin instead of puromycin. The following
target sequences were used in reference to previous studies. For
mouse Tet1 shRNA (shTet1-1), 5′-GCAGATGGCCGTGACACAAAT-3′
[23]; for mouse Tet1 shRNA (shTet1-2), 5′-GAATTA-
CAGTTGTTACGGA-3′ [24] ; for Escherichia coli LacZ shRNA (shLacZ),
5′-GCCCATCTACACCAACGTAAC-3′ [25]. The shRNA-expressing
retroviruses for Tet1 or LacZ (control) were generated as previously
described [26]. C3H10T1/2 cells were suspended in medium con-
taining the virus with 10 μg/mL hexadimethrine bromide and then
centrifuged at 1000g for 1 h at room temperature. The next day,
the medium for these cells was exchanged for DMEM with
500 μg/mL hygromycin. Two weeks after viral infection, the sur-
viving cells were subjected to differentiation.3. Results
3.1. Hydroxylation of methylated cytosine was accompanied by the
progression of chondrocyte differentiation of 10T1/2 cells
The level of DNA methylation ﬂuctuates during cell differ-
entiation processes. We reasoned that 5hmC might also show
differentiation-dependent dynamics. Thus, we investigated the
state of hydroxylation of methylated DNA using cultured me-
senchymal stem cells. First, 3T3-L1 cells were differentiated to
adipocytes, and we observed increased expression of an adipocyte
differentiation marker, the gene for adiponectin (Fig. 1a). DNA
hydroxymethylation showed about 4-fold increased dot intensity
during differentiation (Fig. 1b), consistent with a previous study by
Fujiki’s group [27]. Next, we analyzed the change of DNA hydro-
xymethylation during differentiation from myoblasts to myotubes
using the C2C12 mouse mesenchymal stem cell line. Although
myogenin gene (Myog) mRNA expression (a differentiation marker
of myotubes) was increased from 3 days (Fig. 1c), the remarkable
change of hydroxylation of methylated DNA was not detected
(Fig. 1d). Finally, we examined the alteration of methylated DNA
hydroxylation during chondrocyte differentiation using C3H10T1/
2 cells. C3H10T1/2 cells were differentiated to chondrocytes by
incubation in micromass cultures with BMP2. These micromass-
cultured C3H10T1/2 cells showed a positive reaction to Alcian blue
staining, indicating successful chondrocyte differentiation (Fig. 1e).
Then, a reverse transcription qPCR (RT-qPCR) assessment showed
that the expression of the Col2 gene, a marker gene for pro-
liferative chondrocytes, peaked at 9 days. Collagen 10 (Col10) ex-
pression, a marker gene for hypertrophic chondrocytes, peaked at
12 days (Fig. 1f). These results indicated that micromass-cultured
C3H10T1/2 differentiated to proliferative chondrocytes by 9 days
and to hypertrophic chondrocytes at around 12 days. A dot blot
analysis of differentiating chondrocytes indicated that the level of
5hmC about 3-fold increased with chondrogenesis (Fig. 1g) as well
as with adipocyte differentiation (Fig. 1b). In the remainder of this
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Fig. 1. Altered amounts of 5hmC in cell differentiation. (a) Two days after reaching conﬂuence, 3T3-L1 cells were stimulated by insulin, dexamethasone, 3-isobutyl-1-
methylxanthine and troglitazone for 3 days. RT-qPCR was conducted using the primers for adiponectin as a differentiation marker, and for Rplp0 as a control. RT-qPCR
intensities were normalized to Rplp0 expression. (b) The genomic DNA was subjected to dot blotting using anti-5hmC antibody. Methylene blue staining was carried out for
loading control of DNA. Relative dot intensity normalized to a dot derived from mESc in the same membrane was indicated. (c) C2C12 cells were cultured in medium with
low-concentration FBS (0.5%). RT-qPCR was conducted as in (a). Myogenin expression was validated as a differentiation marker, and Gapdh was used as a control. (d) Dot
blotting was carried out as in (b). (e) C3H10T1/2 cells underwent micromass cultivation with recombinant human BMP2. Alcian blue staining was used to conﬁrm their
differentiation into chondrocytes. (f) The mRNA expression of collagen 2 (Col2), and collagen 10 (Col10) were measured by RT-qPCR as differentiation markers. (g) The
isolated DNA was subjected to dot blotting. Data are represented as means 7 standard deviations (n¼3), ratio to non-differentiation group. *po0.05; **po0.01.
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cells and carried out the following experiments.
3.2. The expression of Tet1 was increased in chondrocytes, and Tet1’s
role in chondrocyte differentiation
Because hydroxylation of methylated DNA was governed by Tetproteins, we measured the expression levels of Tet gene mRNAs in
C3H10T1/2 cells. In the early stage of chondrocyte differentiation,
the expression of Tet1 and Tet2 mRNAs was elevated. In particular,
Tet1’s expression was robustly upregulated ﬁfteen-fold, although
the expression of Tet3 was not dynamically altered (Fig. 2a).
Moreover, Western blotting showed that the amounts of Tet1 and
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Fig. 2. Expression changes of the Tet family of genes in differentiation of chondrocytes and adipocytes. (a) RT-qPCR was carried out using primers for TET1, TET2 and TET3 as
in Fig. 1(f). (b) Cell lysates were extracted at each time point, and they were subjected to Western blotting with the indicated antibodies. COL2 and actin were detected as a
differentiation marker and a loading control, respectively. (c) 3T3-L1 cells were differentiated into adipocytes as in Fig. 1(a), and RT-qPCR was conducted. Data present means
7 standard derivations (n¼3). * po0.05; ** po0.01.
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contrast to chondrocyte differentiation, the dramatic increase of
Tet1 mRNA was not observed in adipocyte differentiation (Fig. 2c),
although the expression Tet2 and Tet3 was slightly increased.
These results suggested that Tet1 expression was enhanced spe-
ciﬁcally in chondrocyte differentiation and not in adipocyte
differentiation.
From these results, we hypothesized that Tet1 might have a
function in transcriptional regulation of chondrocyte differentia-
tion-related genes via the hydroxylation of its promoter DNA. To
address this hypothesis, we investigated the effect of Tet1-knock-
down on Col2 and Col10 expression in chondrocyte differentiation.
Retroviral shRNA against Tet1 reduced the expression to approxi-
mately 50% at 9 days (Fig. 3a). Under this condition, the expression
of Col2 (Fig. 3b) and Col10 (Fig. 3c) was signiﬁcantly decreased by
shTet1. This result suggested that Tet1 might play a role in the
progression of chondrocyte differentiation.
3.3. Locus-speciﬁc hydroxylation of methylated DNA during chon-
drocyte differentiation
In this study, we showed that the hydroxylation of methylated
DNA occurred during chondrocyte differentiation (Fig. 1g). How-
ever, precisely where this hydroxylation occurred was still unclear.
Therefore, we analyzed the change in the hydroxylation level ofthe Igf1 gene promoter as a model for upregulated genes and the
promotion of chondrocyte differentiation. Igf1 expression is gov-
erned by growth hormone (GH), which is secreted from the liver,
muscle, adipose tissue, osteoblasts and chondrocytes [28]. Our
experiment showed that the expression of the Igf1 gene was ac-
companied by chondrocyte differentiation of C3H10T1/2 cells
(Fig. 4a). Next, we investigated the alteration of DNA methylation
status of the Igf1 gene in chondrocyte differentiation. According to
the NCBI database, the promoter of the Igf1 gene has alternative
transcription start sites for Igf1 mRNA (NM_001111275 or
NM_001111274/NM_00111276), and there are two CpG islands in
this region (Fig. 4b). We designed two primers for quantitative PCR
in these CpG islands (named CGI1, and CGI2 as indicated in
Fig. 4b), and a primer 2000 base-pairs upstream from the
NM_001111275 transcription start site (2k) as a control. Every
primer ampliﬁed the fragments containing the CCGG nucleotides.
Restriction enzymes MspI and HapII recognized the CCGG se-
quences and digested the CpG dinucleotides. MspI could digest
CCGG independent of the methylation status of CpG. On the other
hand, HapII could digest CpG only when it was not methylated.
The qPCR analysis combined with the digestion of genomic DNA
revealed that the 2k and CGI1 regions were heavily methylated,
whereas the CGI2 region was hardly methylated in un-
differentiated C3H10T1/2 cells (Fig. 4c). We then examined the
hydroxylation level of methylated cytosine in the three regions
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Fig. 3. Tet1 knockdown in C3H10T1/2 cells downregulated the expression of Col2
and Col10 during chondrocyte differentiation. (a) (b) (c) Tet1 knockdown cells were
generated using retroviral shRNA. For a control, a shRNA against LacZ was in-
troduced into the cells. After these cells were differentiated to chondrocytes, RT-
qPCR using primers for Tet1 (a), Col2 (b), and Col10 (c) were conducted. Data are
presented as means 7 standard deriviations (n¼3), ratio to shLacZ at day zero
samples. **po 0.01.
R. Ito et al. / Biochemistry and Biophysics Reports 5 (2016) 134–140138using the BGT reaction and MspI digestion. BGT could transfer the
glycosyl group to only 5hmC, and glycosylated 5hmC was not di-
gested by MspI. This experiment showed that CpG dinucleotides in
CGI1 and CGI2 regions were hydroxylated in differentiated cells
although the 2k region was not (Fig. 4d). Furthermore, we found
that the extent of hydroxylation in CGI2 is much higher than that
in CGI1. These results showed that the hydroxylation of methy-
lated DNA by TET proteins had a site preference in the Igf1
promoter.4. Discussion
The relationship between epigenomic status and cell identity
has been studied extensively. With regard to DNA methylation,
when C3H10T1/2 cells were treated with 5-azacytidine, whichinhibits DNA methyltransferase (DNMT) activity, there was a de-
crease in DNA methylation, and cells differentiated into chon-
drocytes, adipocytes and myocytes [12,29]. Moreover, the hydro-
xylation of methylated DNA by Tet family proteins led to the re-
moval of the methyl groups from cytosine, according to recent
work [4,5]. Based on these past reports, we postulated that Tet
proteins play a role in epigenetic regulation during cell
differentiation.
The expression pattern of the Tet family of genes varies with
speciﬁc organs, and it was found that Tet1’s expression was
abundant in embryonic stem cells [23]. In this report, we showed
that the expression of Tet1 mRNA and protein were speciﬁcally
enhanced during the differentiation of chondrocytes (Fig. 2a, b).
Recently, some reports suggested that Tet1 is highly expressed in
chondrocytes [30,31]. For example, de Andres’s group has shown
that the expression of Tet1 in human fetal bone cells was higher
than in adult chondrocytes [30], and Haseeb’s group has revealed
that Interleukin 1β (IL-1β) and Tumor necrosis factor α (TNF-α),
known as pro-inﬂammatory cytokines, reduced the expression of
Tet1 and the amount of 5hmC in human primary chondrocytes
[31]. Our observations regarding the increased level of Tet1 ex-
pression in chondrocytes agreed with these reports. Together,
these ﬁndings emphasize the signiﬁcance of Tet1 to bone
physiology.
The Igf1 gene is expressed in the liver, chondrocytes and else-
where [28]. So far, the mechanisms regulating Igf1 transcription
have primarily been studied in the liver. It has been well docu-
mented that GH induces Igf1 expression via the receptor signaling
pathway [28]. The mechanisms regulating Igf1 transcription in
chondrocytes have also been reported [32]. However, the epige-
netic alterations of the Igf1 promoter in chondrocytes have re-
mained unclear. In this study, we revealed that the expression of
Igf1 mRNA was elevated in C3H10T1/2 cells, a line used as a
chondrocyte differentiation model (Fig. 4a). Moreover, a speciﬁc
CpG island (CGI2) showed a low methylation level, whereas other
regions (2k and CGI1) were more highly methylated in
C3H10T1/2 cells (Fig. 4c). Furthermore, the hydroxylation of 5mC
was detected in both CGI1 and CGI2. Of note, the amount of 5hmC
in CGI2 was increased four-fold (Fig. 4d). These results suggested
that the epigenetic states of the Igf1 promoter might change dur-
ing chondrocyte differentiation.
Our results demonstrated that during chondrocyte differentia-
tion, hydroxylation by Tet proteins took place in speciﬁc regions
(Fig. 4d). Tet1 and Tet3 have a CXXC domain that recognizes the
non-methylated CpG sequences [33]. Though Tet2 does not have it,
it was reported that Tet2 could interact with Inhibition of the Dvl
and Axin complex (IDAX) containing the CXXC domain [34]. In this
study, we showed that CGI2 region was not frequently methylated
before differentiation, and that the 5mC of CGI2 was hydroxylated
after chondrocyte differentiation. These results support the hy-
pothesis that Tet proteins recognized non-methylated CpG via its
CXXC domain and probably hydroxylated the remaining portion of
the methylated CpG.
In this study, we revealed DNA hydroxymethylation of Igf1
promoter in differentiated chondrocyte (Fig. 4d). This result sug-
gested that Igf1 was one of the Tet1’s target genes. On the other
hand, we showed the necessity of Tet1 for chondrocyte differ-
entiation (Fig. 3). However, we did not clarify the reason why the
down-regulation of Tet1 led to reduce the differentiation efﬁciency
to chondrocyte. To answer this question we need to explore the
target genes of TET1 by the genome-wide analysis in future efforts.
This experiment would identify the target gene of Tet1 regulating
the chondrocyte differentiation, and reveal more detailed me-
chanism of chondrocyte differentiation regulated by Tet1.
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Fig. 4. The hydroxylation of methylated DNA of the Igf1 promoter in chondrocyte differentiation. (a) RT-qPCR was carried out using a primer for Igf1 as in Fig. 1(f). Data
present means 7 standard deriviations (n¼3). ** po0.01. (b) Schematic representation of the Igf1 promoter. There are two transcription start sites (arrows) for
NM_001111275, and NM_001111274/6. The Igf1 promoter has two CpG islands (solid boxes) between the ﬁrst exons (empty boxes). For the following experiments, primers
were designed for 2,000 base pairs upstream from the transcription start site (2k) and at two CpG islands (CGI1 and CGI2). (c) Genomic DNA derived from undifferentiated
C3H10T1/2 cells was digested by MspI or HapII or not treated. qPCR was conducted using 2k, CGI1 and CGI2 primers. qPCR intensity was normalized to uncut DNA samples.
Data present means 7 standard deriviations (n¼3). **po0.01 (d) DNA was extracted from undifferentiated cells (day 0) or differentiated cells (day 12) and was reacted
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